CHROMagar™ VRE


Order References

Please use these references when contacting with our:

  • 5000 mL Pack …….. VR952
    Include: base VR952(B) + supplement VR952(S)
  • 10 kg Pack …………… VR953-10kg
    Include: base VR953-10kg(B) + supplement VR953-150(S)

In Stock

Information Acinetobacter

Colonies Appearance

Colonies Appearance
ERV. faecalis/ERV. faecium

ERV. faecalis/ERV. faecium

Pink to mauve

E. gallinarum/E. casseliflavus

E. gallinarum/E. casseliflavus

Blue or inhibited

Performance

Performance

There are two types of vancomycin resistance in Enterococci. The first type is intrinsic resistance (mostly Van C type but also Van D, Van E, Van F etc) found in E. gallinarum and E. casseliflavus/E. flavescens and demonstrates a low-level resistance to vancomycin. The second type of vancomycin resistance in enterococci is acquired resistance (Van A & Van B types), mostly seen in E. faecium and E. faecalis. Therefore, to avoid the spread of this resistance to more virulent pathogens (S. aureus, for instance) it is crucial to promptly detect the presence of any of these two species in the patient, and accurately differentiate them from other Enterococci.

 

Knowledge of the type of resistance is critical for infection control purposes. Van A and Van B genes are transferable and can spread from organism to organism. In contrast, Van C genes are not transferable, have been associated less commonly with serious infections, and have not been associated with outbreaks – from CDC guidelines

 

Vancomycin-resistant Enterococcus (VRE) infections are especially aggressive and have been associated with mortality rates approaching 60 % to 70 %.

 

Intended Use :


CHROMagar™ VRE is a selective and differential chromogenic medium, containing 6 mg/L of vancomycin, intended for use in the qualitative direct detection of vanA/vanB transmissible VRE-type gastrointestinal colonization with vancomycin-resistant Enterococcus faecium and Enterococcus faecalis (VRE) to aid in the prevention and control of VRE in healthcare settings. The test is performed with rectal swab and stools from patients to screen for VRE colonization. Results can be interpreted after 24 h of aerobic incubation at 35-37 °C.


The medium can also be used as an early warning indicator for diagnostic tests of infections to signal the possible presence of multi drug-resistant bacteria. This use does not replace the institution’s protocols. CHROMagar™ VRE is not intended to diagnose VRE infection nor to guide nor monitor treatment for infections. A lack of growth or the absence of pink colonies on CHROMagar™ VRE does not preclude the presence of VRE. Further identification, susceptibility testing, and epidemiological typing is needed on suspect colonies.

1.  Simple, fast and reliable tool : for the direct detection of VRE strains with transmissible resistance : this is a precious help in the implementation of the appropriate control measures to prevent the spread of VRE.

2. Intense colonie colours: In CHROMagar™ VRE, VRE. faecalis et VRE. faecium strains are easily distinguishable by the colony colour. In the contrary, in the classical agar for the detection of VRE (Bile Esculine Agar supplemented with vancomycin) :


(I) there is no différenciation between E. faecalis/ E. faecium ; (II) it often leads to false positives of other esculine hydrolising bacteria (like Lastococcus, Pediococcus...) ; (III) the black "cloud" makes plate reading difficult as well as the choice of the proper colony for further confirmatory tests.

3. Flexibility : CHROMagar™ VRE is supplied with a more than 18 months shelf life. This allows for flexibility of use, whether in an epidemic situation with many patients to screen, or whether for random surveillance of cultures.

Composition

Technical Documents

PDF CHROMagar™ VRE MSDS
PDF Leaflet
PDF Instructions for Use
PDF Instructions for Use USA
Scientific Publications

Scientific Publications

2023

Comparison of Five Different Selective Agar for the Detection of Vancomycin-Resistant Enterococcus faecium

Alessa L. Boschert, Franca Arndt, Axel Hamprecht, Martina Wolke and Sarah V. Walker

📄 Publication

2023

Identification of microorganisms grown on chromogenic media by MALDI-TOF MS

Petra Lüthje, Arthur B. Pranada, Duncan Carruthers-Lay, Marc Desjardins, Olivier Gaillot, David Warehame, Holly Ciesielczuk, Volkan Özenci

📄 Publication

2018

Detection of vancomycin-resistant enterococci using chromogenic selective medium

Fyodorova A.V., Klyasova G.A. National Medical Research Center of Hematology, Moscow, Russia

📄 Publication

2017

Identification of microorganisms grown on chromogenic media by MALDI-TOF MS

Petra Lüthje, Arthur B. Pranada, Duncan Carruthers-Lay, Marc Desjardins, Olivier Gaillot, David Wareham , Holly Ciesielczuk, Volkan Özenci

📄 Publication

2013

Performance of CHROMagar VRE medium for the detection of Airborne Vancomycin-resistant/sensitive Enterococcus species

Pao-Kuei Hsiao, Chieh-Chen Cheng, Kai-Chih Chang, Lih-Ming Yiin, Chia-Jung Hsieh and Chun-Chieh Tseng Aerosol Science and Technology

📄 Publication

2012

Evaluation of CHROMagar compared with enterococcosel broth for the isolation of vancomycin resistant enterococci

Hindley et al Department of microbiology and infectious diseases ASM 2012

📄 Publication

2012

A novel method “CHROMagar” for screening vancomycin-resistant enterococci (VRE) isolates

Massoud Hajia1,2, Mohammad Rahbar1,2* and Mona Mohammad Zadeh3 1Deparment of Microbiology, Iranian Reference Health laboratory, Ministry of Health and Medical Educations, Tehran, Iran. 2Antibiotic Resistance Research Center, Tehran University of Medical

📄 Publication

2011

Evaluation of Three Chromogenic Media for Detection of Vancomycin-Resistant Enterococci in a tertiary-care Hospital M.L. Miller et al.

Kingston General Hospital, ON, Canada. Poster P26, CACMID 2011.

📄 Publication

2011

Evaluation of Three Commercial Chromogenic Media and BEAA + van 6ug/mL for the Detection of Vancomycin-Resistant Enterococcus (VRE)

Kornherr, Department of Microbiology Gamma Dynacare Medical Laboratories, Ottawa and Toronto, Ontario, Canada. ASM Meeting Poster 2010

📄 Publication

2011

Evaluation of Broth Enrichment for the Detection of Vancomycin Resistant Enterococci on Two Chromogenic Media

M.L. Miller et al. Queen’s University School of Medicine, Department of Pathology and Molecular Medicine, & Kingston General Hospital, Kingston, ON, Canada ASM 2011

📄 Publication

2009

Evaluation of a ColorexTM chromogenic media and Bile-esculin azide agar with 6ug vancomycin for the detection of Vancomycin Resistant Enterococcus faecalis and Enterococcus faecium (VRE)

Almohri et al. Poster 2009

📄 Publication

2009

Evaluation of Chromogenic Agar for Screening Vancomycin-resistant Enterococcus (VRE)

Pillai et al. Poster 2009

📄 Publication

2009

Utility of CHROMagar VRE for the Identification of VRE in Epidemiology Screens

Jones et al. Poster 2009.

📄 Publication

2009

Comparison of two chromogenic media for selective isolation of vancomycin-resistant enterococci from stool specimens

Heidrun Peltroche-Llacsahuanga, Janetta Top, Josefine Weber-Heynemann, Rudolf Lutticken and Gerhard Haase Journal of Clinical Microbiology

📄 Publication

2008

Evaluation of Two Chromogenic Media for the Isolation of VRE (Vancomycin Resistant Enterococci)

C.C. Rutherford. et al. 2008. Poster presented during 2008 ASM meeting at Boston (USA)

📄 Publication

2008

Evalucion de un Medio Cromogénico (CHROMagar) Para La Detection de Enterococos Resistentes a Vancominica (EVR) a partir de Hisopados Rectales

Blanco, M.A. ; Lopardo, H.A. 2008. Argentina

📄 Publication

2007

A novel Chromogenic Agar Medium for the Detection of Vancomycin Resistant Enterococci (VRE)

John Merlino. et al. 2007, ASM adelaid - Australia

📄 Publication

2020

A genomic epidemiology study of multidrug-resistant Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii in two intensive care units in Hanoi, Vietnam

M. Estée Torok, Zamin Iqhal et al. MedRxiv December 2020

📄 Publication
All publications

Related Product(s)

main.add_cart_success